triiodothyronine has been researched along with Raynaud Disease in 8 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The underlying diseases were systemic lupus erythematosus (n = 5), systemic sclerosis (n = 3) and rheumatoid arthritis (n = 1)." | 1.28 | Treatment of Raynaud's phenomenon with triiodothyronine corrects co-existent autonomic dysfunction: preliminary findings. ( Dessein, PH; Gledhill, RF; Van der Merwe, CA, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ihler, G | 1 |
| Chami-Stemmann, H | 1 |
| Gledhill, RF | 3 |
| Dessein, PH | 4 |
| Van der Merwe, CA | 2 |
| Shpigel', AS | 1 |
| Harada, N | 1 |
| Nakamoto, M | 1 |
| Kohno, H | 1 |
| Kondo, H | 1 |
| Tanaka, M | 1 |
| Morrison, RC | 1 |
| Lamparelli, RD | 1 |
1 trial available for triiodothyronine and Raynaud Disease
| Article | Year |
|---|---|
Triiodothyronine treatment for Raynaud's phenomenon: a controlled trial.
Topics: Adolescent; Adult; Aged; Body Temperature; Double-Blind Method; Female; Heart Rate; Humans; Male; Mi | 1990 |
7 other studies available for triiodothyronine and Raynaud Disease
| Article | Year |
|---|---|
7-oxo-DHEA and Raynaud's phenomenon.
Topics: Clinical Trials as Topic; Dehydroepiandrosterone; Humans; Models, Theoretical; Raynaud Disease; Ster | 2003 |
Treatment of Raynaud's phenomenon with triiodothyronine corrects co-existent autonomic dysfunction: preliminary findings.
Topics: Adult; Arousal; Arthritis, Rheumatoid; Autonomic Nervous System Diseases; Blood Pressure; Dose-Respo | 1992 |
[Blood thyroid hormone levels and their reaction to thyroliberin in vibration-induced pathology].
Topics: Fingers; Humans; Male; Occupational Diseases; Raynaud Disease; Thyrotropin-Releasing Hormone; Thyrox | 1990 |
Hormonal responses to cold exposure in subjects with vibration syndrome.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Cold Temperature; Fingers; Hormones; Humans; Male; Middle | 1990 |
Tri-iodothyronine in Raynaud's phenomenon: further objective evidence of its beneficial effect.
Topics: Dose-Response Relationship, Drug; Drug Evaluation; Humans; Male; Middle Aged; Raynaud Disease; Triio | 1988 |
Treatment of Raynaud's phenomenon with large doses of triiodothyronine: a pilot study.
Topics: Adult; Female; Humans; Pilot Projects; Raynaud Disease; Triiodothyronine | 1987 |
Reserpine in Raynaud's phenomenon.
Topics: Humans; Injections, Intra-Arterial; Raynaud Disease; Reserpine; Triiodothyronine; Vasodilator Agents | 1970 |